Big Pharma

FDA’s Flawed Approach to Accelerated Drug Approvals

FOLLOW THE MONEY –

July 25, 2022 – NPR found that 42% of currently outstanding confirmatory studies – or 50 of them – either took more than a year to begin following accelerated approval or hadn’t started at all. Nineteen of those required studies still haven’t started three years or more after accelerated approval. Four of them haven’t started more than 10 years later. That means many drugs that made it to market with an accelerated approval are being used – sometimes for years – without patients, doctors or regulators knowing if they really work.

more@NPR

Leonard Buschel

Recent Posts

An Interview with NuQI’s John Wright

EMR MATTERS – October 2024 - The challenge is that many in the behavioral health…

3 days ago

California Wants Social Media To Have ‘black box warning’ For Kids

TOO LITTLE, TOO LATE? – Dec. 19, 2024 - Assembly Bill 56 (AB 56) proposes…

6 days ago

Lily Allen Shares the Moment She Hit ‘Rock Bottom’

AND STOPPED DIGGING – Dec. 4, 2024 - In a new interview with The Times,…

6 days ago

170 Million Americans Learn Deadly Toxin is Toxic

NOT JUST IN PENCILS – Dec. 8, 2024 - Americans born before 1966 experienced “significantly…

6 days ago

Famous Child Star After Opening Up About Addiction

AS SUCCESSFUL AS EVER – Dec. 3, 2024 - Family Affair actor Johnny Whitaker looked…

6 days ago

Top 10 Things Families Can Do to Avoid Common Rehab Pitfalls

ALANON Plus – Dec. 7, 2024 - A high percentage of treatment failures occur due…

6 days ago